Stifel Financial Corp Sells 828 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Stifel Financial Corp reduced its holdings in ICU Medical, Inc. (NASDAQ:ICUI) by 19.3% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 3,454 shares of the medical instruments supplier’s stock after selling 828 shares during the period. Stifel Financial Corp’s holdings in ICU Medical were worth $629,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently modified their holdings of the business. Allworth Financial LP grew its stake in shares of ICU Medical by 100.0% in the third quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock worth $36,000 after acquiring an additional 100 shares during the last quarter. Xponance Inc. raised its position in shares of ICU Medical by 6.0% during the second quarter. Xponance Inc. now owns 1,977 shares of the medical instruments supplier’s stock valued at $235,000 after buying an additional 112 shares during the last quarter. Equitable Trust Co. lifted its stake in shares of ICU Medical by 2.2% in the third quarter. Equitable Trust Co. now owns 5,213 shares of the medical instruments supplier’s stock valued at $950,000 after buying an additional 112 shares during the period. Hexagon Capital Partners LLC grew its position in ICU Medical by 162.7% during the third quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier’s stock worth $36,000 after buying an additional 122 shares in the last quarter. Finally, Connable Office Inc. increased its stake in ICU Medical by 6.4% during the third quarter. Connable Office Inc. now owns 2,031 shares of the medical instruments supplier’s stock valued at $370,000 after acquiring an additional 122 shares during the period. 96.10% of the stock is currently owned by institutional investors and hedge funds.

ICU Medical Trading Up 1.4 %

Shares of ICU Medical stock opened at $156.89 on Thursday. ICU Medical, Inc. has a 12-month low of $86.80 and a 12-month high of $196.26. The stock has a market capitalization of $3.84 billion, a P/E ratio of -34.33 and a beta of 0.62. The company has a 50-day simple moving average of $167.36 and a 200 day simple moving average of $154.03. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on ICUI shares. Needham & Company LLC reissued a “hold” rating on shares of ICU Medical in a report on Wednesday, November 13th. StockNews.com raised shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Wednesday, November 20th. KeyCorp increased their price objective on shares of ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a research note on Wednesday, November 13th. Raymond James lifted their target price on shares of ICU Medical from $158.00 to $190.00 and gave the company an “outperform” rating in a research report on Thursday, September 12th. Finally, Jefferies Financial Group raised shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price target for the company in a research report on Wednesday, December 11th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, ICU Medical currently has an average rating of “Moderate Buy” and a consensus target price of $199.67.

Insiders Place Their Bets

In related news, Director David C. Greenberg sold 972 shares of the stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $158.11, for a total transaction of $153,682.92. Following the sale, the director now directly owns 5,037 shares in the company, valued at $796,400.07. This represents a 16.18 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Vivek Jain sold 12,000 shares of ICU Medical stock in a transaction on Friday, November 1st. The shares were sold at an average price of $171.84, for a total value of $2,062,080.00. Following the completion of the transaction, the chief executive officer now owns 104,593 shares of the company’s stock, valued at approximately $17,973,261.12. The trade was a 10.29 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 40,364 shares of company stock valued at $6,869,878. 6.70% of the stock is currently owned by insiders.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.